Antidiabetic and renoprotective effect of Anogeissus acuminata leaf extract on experimentally induced diabetic nephropathy

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 29, Issue 4, 2018, Pages 359-364

  Navale, Archana M ^a   Paranjape, Archana ^b  

^a Parul Institute of Pharmacy and Research   (India)

^b Edutech Learning Solutions Pvt Ltd   (India)

Author keywords

Anogeissus pendula; antidiabetic; diabetic complications; nephropathy; nephroprotective

Indexed keywords

ANOGEISSUS ACUMINATA EXTRACT; CREATININE; GLUCOSE; ISOPHANE INSULIN; METHANOL; PLANT EXTRACT; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; ANTIOXIDANT; PROTECTIVE AGENT; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOGEISSUS ACUMINATA; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DOSE RESPONSE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; KIDNEY MASS; MALE; MEDICINAL PLANT; NONHUMAN; OXIDATIVE STRESS; PLANT LEAF; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION; URINE VOLUME; ANIMAL; BLOOD; CHEMICALLY INDUCED; CHEMISTRY; COMBRETACEAE; COMPLICATION; EXPERIMENTAL DIABETES MELLITUS; KIDNEY; METABOLISM; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BLOOD UREA NITROGEN; COMBRETACEAE; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; HYPOGLYCEMIC AGENTS; KIDNEY; MALE; OXIDATIVE STRESS; PLANT EXTRACTS; PLANT LEAVES; PROTECTIVE AGENTS; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 85045838260     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/jbcpp-2017-0190     Document Type: Article

References (26)

1. DeFronzo RA. Diabetic nephropathy: Etiologic and therapeutic considerations. Diabetes Rev 1995;3:510-64.
2. Pullaiah K, Naidu C. Antidiabetic plants in India and herbal based antidiabetic research, 2nd ed. New Delhi: Regency Publications, 2003:86-7.
3. Manosroi J, Moses ZZ, Manosroi W, Manosroi A. Hypoglycemic activity of Thai medicinal plants selected from the Thai/Lanna Medicinal Recipe Database MANOSROI II. J Ethnopharmacol 2011;138:92-8.
4. Navale AM, Paranjape AN. Phytochemical screening and HPTLC fingerprinting of Anogeissus acuminata extracts. Int J Res Ayurveda Pharm 2016;7:207-9.
5. Hemamalini K, Vijusha M. Antidiabetic activity of methanolic extracts of leaves of Anogeissus acuminata Roxburgh ex candolle and Solanum pubescens Willd by alloxan induced model in rats. Pharm Lett 2012;4:1445-60.
6. Zaruwa MZ, Manosroi J, Akihisa T, Manosroi A. Castalagin from Anogeissus acuminata (Roxb. ex. DC) Guill. Ex. Perr, a potent hypoglycaemic agent. Int J Curr Res Acad Rev 2015;3:147-52.
7. Navale AM, Paranjape AN. In vitro antioxidant and PTP inhibitory activity of methanolic extract of Anogeissus acuminata leaf and bark. J Pharm Res 2016;10:65-8.
8. Aebi H. Catalase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. New York: Academic Press Inc, 1974:673-84.
9. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;61:882-8.
10. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
11. Kaminskas A, Mazeikiene A. Biochemistry laboratory manual, 1st ed. [ebook]. Vilnius: Vilnius University, Faculty of Medicine, 2012: 9. Available at: Http://www.fblm.mf.vu.lt/wpcontent/ uploads/2014/02/Lab-darbai-Angliskai.pdf. Accessed 09 Jan 2014.
12. Matsumoto K, Hatano M. Production of interleukin 1 in glomerular cell cultures from rats with nephrotoxic serum nephritis. Clin Exp Immunol 1989;75:123.
13. Shen SC, Chang WC. Hypotriglyceridemic and hypoglycemic effects of vescalagin from Pink wax apple [Syzygium samarangense (Blume) Merrill and Perry cv. Pink] in high-fructose dietinduced diabetic rats. Food Chem 2013;136:858-63.
14. Vessal M, Hemmati M, Vasei M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp Biochem Physiol C Toxicol Pharmacol 2003;135:357-64.
15. Coskun O, Kanter M, Korkmaz A, Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Pharmacol Res 2005;51:117-23.
16. Abdelmoaty MA, Ibrahim MA, Ahmed NS, Abdelaziz MA. Confirmatory studies on the antioxidant and antidiabetic effect of quercetin in rats. Indian J Clin Biochem 2010;25:188-92.
17. Arora MK, Singh UK. Molecular mechanisms in the pathogenesis of diabetic nephropathy: An update. vascul Pharmacol 2013;58:259-71.
18. Cao Z, Cooper ME. Pathogenesis of diabetic nephropathy. J Diabetes Investig 2011;2:243-7.
19. De Zeeuw D, Ramjit D, Zhang Z, Ribeiro AB, Kurokawa K, Lash JP, et al. Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: A post hoc analysis of RENAAL. Kidney Int 2006;69:1675-82.
20. Nakamura Y, Myers BD. Charge selectivity of proteinuria in diabetic glomerulopathy. Diabetes 1988;37:1202-11.
21. Pietravalle P, Morano S, Cristina G, De Rossi MG, Mariani G, Cotroneo P, et al. Charge selectivity of proteinuria in type I diabetes explored by Ig subclass clearance. Diabetes 1991;40:1685-90.
22. Morano S, Pietravalle P, De Rossi MG, Mariani G, Cristina G, Medici F, et al. A charge selectivity impairment in protein permselectivity is present in type 2 diabetes. Acta Diabetol 1993;30:138-42.
23. Ruggenenti P, Remuzzi G. Time to abandon microalbuminuria?. Kidney Int 2006;70:1214-22.
24. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: A systematic overview of the literature. Arch Intern Med 1997;157:1413-8.
25. Gomes IB, Porto ML, Santos MC, Campagnaro BP, Pereira TM, Meyrelles SS, et al. Renoprotective, anti-oxidative and anti-apoptotic effects of oral low-dose quercetin in the C57BL/6J model of diabetic nephropathy. Lipids Health Dis 2014;13:184.
26. ArunaDevi R, Lata S, Bhadoria BK, Ramteke VD, Kumar S, Sankar P, et al. Neuroprotective effect of 5, 7, 3', 4', 5'-pentahydroxy dihdroflavanol-3-O-(2''-O-galloyl)-β-d-glucopyranoside, a polyphenolic compound in focal cerebral ischemia in rat. Eur J Pharmacol 2010;626:205-12.